Being overweight as a child and young adult linked to bowel cancer risk
A higher birth weight was also associated with an increased chance of developing the disease, according to a study.
Experts in the Netherlands reviewed 37 studies on body weight in early life and the risk of colorectal cancer – also known as bowel cancer – in adults.
Cancer is a complex disease which develops over several decades, so better understanding of its early origins is critical for more effective prevention efforts and understanding the research gaps
The research, which is published in the International Journal of Cancer, found an increase in BMI of 5kg/m2 heightened the risk of bowel cancer by 12% in people aged 18 to 25.
In youngsters aged 10 to 19, an increased BMI was linked to a 5-18% risk of developing the disease, while in children aged two to nine, BMI was linked to a higher risk of colon cancer.
Meanwhile, each 1kg increase in birth weight was linked to a 9% bowel cancer risk, the study found.
Dr Dieuwertje Kok, associate professor of nutrition and cancer at Wageningen University & Research, said: 'Although the relationship between adult body size and colorectal cancer risk is well-documented, the potential influence of measures of body size during early life is less understood.
'The team was excited to review results from 37 publications that explored birth weight, as well as body mass index across different early life stages.
'This study bridges the existing knowledge gap and enhances our understanding of how early life factors may affect colorectal cancer risk in adults.'
Bowel cancer is the fourth most common cancer in the UK, with almost 44,000 new diagnoses every year.
The analysis is part of World Cancer Research Fund International's Global Cancer Update Programme.
Dr Helen Croker, assistant director of research and policy at the World Cancer Research Fund, added: 'Cancer is a complex disease which develops over several decades, so better understanding of its early origins is critical for more effective prevention efforts and understanding the research gaps.
'The results of this study show that raised body mass index across childhood through young adulthood is an important risk factor for colorectal cancer.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Daily Mail
5 hours ago
- Daily Mail
Hyped longevity pill loved by biohacker Bryan Johnson fails to stop aging, study reveals
A supplement beloved by Bryan Johnson and other biohackers for its age-defying properties might be flawed, new research reveals. Previous animal studies have suggested taurine, an essential amino acid that supports immune health and nervous system function, declines with age. It's found naturally in the body, in various high-protein foods, and it is also added to energy drinks for its potential to enhance mental and athletic performance. It was thought that replenishing it by taking supplements could keep the body young by protecting against damage to DNA and cells. Off the back of the research in 2023, taurine was quickly picked up by those looking to fight the effects of aging and Johnson became one of its proponents, with it added to his daily roster of supplements. But scientists behind a new study claim taurine doesn't actually decline with age; instead it either increases or stays stable and can vary wildly from person to person. Therefore, the amino acid is not a good indicator of age-related changes as originally thought, and taking a taurine supplement may have no effect whatsoever on a person's longevity. What's more, other studies have shown high doses or prolonged taurine intake can actually cause a variety of side effects, including gastrointestinal discomfort, kidney strain, and in rare cases, liver pain or even leukemia. The human body uses taurine for actions in cells, such as energy production, and helps the body process bile acid and balance fluids, salts and minerals. The amino acid also has important functions in the heart and the brain and helps support nerve growth. There are no current recommendations on how much taurine a person should consume or what adequate levels are in the body. However, lower levels have been associated with an overactive thyroid, vision impairment and kidney dysfunction. It may benefit people with heart failure and prevent their condition from worsening by lowering blood pressure and calming the nervous system. It has antioxidant and anti-inflammatory properties and has been studied for its role in energy production and improving exercise performance. Commenting on the findings of the new study, Joseph Baur, a professor of physiology at the University of Pennsylvania, told Live Science: 'The main takeaway is that a decline in taurine is not a universal feature of aging.' Scientists analyzed data from both humans and animals. Included in the research were 1,000 people aged 20 to 100 years old who had participated in several studies from around the world. In animals, the team analyzed blood from rhesus macaque monkeys ages three to 32 and blood from lab mice ages nine to 27 months old. What surprised the researchers is that over time, taurine levels actually increased with age. Thus, study co-author Maria Emilia Fernandez, a postdoctoral fellow at the National Institute on Aging, said taurine is 'unlikely to serve as a good biomarker of aging'. Meanwhile Rafael de Cabo, chief of the Translational Gerontology Branch at the National Institute on Aging who was another co-author of the study, added: 'It's not a reliable biomarker of anything yet. 'I think that we need to be digging into the basic mechanisms… before it can be used reliably as a marker.' Vijay Yadav, an associate professor at Rutgers New Jersey Medical School who co-authored the 2023 taurine study, is currently taking part in an ongoing clinical trial to see if it could have any effect on aging in middle-aged humans.
The Independent
6 hours ago
- The Independent
The surprising health benefits of fecal transplants
Fecal microbiota transplants, used to restore gut health, involve transferring stool from a healthy donor to a recipient. A new University of Chicago study in mice reveals potential long-lasting, unintended health consequences from these transplants due to microorganisms colonizing the entire intestinal tract, creating regional gut mismatches. The study found that transplanted microbes altered intestinal environments, affecting metabolism, behavior, energy balance, and liver function in mice. Researchers advocate for caution and suggest using microorganisms from all regions of the intestine, not just the colon, for transplants. Dr. Eugene Chang, the study's senior author, notes that fecal microbiota transplants can cause changes in host-microbe relationships in different bowel regions that may be difficult to reverse.
The Independent
8 hours ago
- The Independent
‘Poop transplants' have been happening for decades. Now researchers have identified some unintended consequences
Fecal microbiota transplants are common medical procedures dating back decades that can help restore the gut health of people with colon infections - but scientists now warn of newly discovered consequences from the procedure. The 'poop transplant' is the transfer of the stool of a healthy donor to a recipient. The stool contains beneficial bacteria that can improve the patient's gut bacteria, which guards immune health and helps to regulate metabolism. They are approved by the Food and Drug Administration to treat people with common C. diff infections that may cause severe gastrointestinal symptoms and inflammation in hospital patients who have been on antibiotics. Roughly 48,000 procedures are done each year. Now, University of Chicago researchers say a study in mice and experiments with human tissue have revealed some long-lasting and unintended consequences due to transplanting microorganisms from only one section of the digestive tract. 'I think it's a bit of a wakeup call to the field that maybe we shouldn't willy-nilly put large bowel microbes into different parts of the intestine that shouldn't be there,' Dr. Orlando 'Landon' DeLeon, postdoctoral researcher at the university, said in a statement. 'If we're designing good therapeutics, we should be aware of the importance of matching the regional microbiota to their proper environments, so that we provide better overall health benefits.' DeLeon is the lead author of the new research, which was published on Friday in the journal Cell. To reach these conclusions, the authors gave three groups of mice transplants of microorganisms from the middle part of the small intestine that connects to the colon, and a standard fecal transplant from the colon. The test showed that the microorganisms from each transplant were able to colonize the entirety of the intestinal tract in the mice -- not just certain regions. This created what they called regional gut mismatches, lasting for up to three months following a transplant. The microbes also altered their new intestinal environments, 'terraforming' the lining in ways that caused changes in the recipient's metabolism, behavior and energy balance. There were shifts in liver metabolism, including activity in genes associated with immune function. The mice also exhibited different eating behaviors. The gut has several distinct regions with vastly different microbial ecosystems. Imbalances in gut bacteria have been tied to a risk of cancer. 'There are microbes along the entire intestinal tract, and we just study predominately the last third of it (the colon),' DeLeon said. 'So, how can you expect [a transplant], with microbes from a third of the intestinal tract at the end of it, to fix the rest of the intestine?' What this means for human patients may be murky right now, but the authors say more caution is needed with the transplants going forward. They advocate for an approach that would transfer microorganism from all regions of the intestine and not just largely from the colon. In the future, they plan to conduct further study related to how different microbes exert their influence in different parts of the intestine and how the gut regions terraformed by microbiota mismatches can be restored. 'We have absolutely no idea what's in FMT, except that it's a combination of microbes,' Dr. Eugene Chang, the Martin Boyer Professor of Medicine at the university and senior author of the study, said. 'But even a single FMT will cause a change in the host-microbe relationships in these very different regions of the bowel that may be very difficult to reverse.'
